cancer

Stäubli Robotics and Quantum Surgical create ‘centre of excellence’ to develop oncology robotics

July 6, 2020 by David Edwards Leave a Comment

Stäubli Robotics and Quantum Surgical have launched a strategic partnership to create a centre of excellence in oncology robotics.

The alliance aims to strengthen the role of robotics in minimally invasive cancer treatments and to use the combined expertise of each company to create a world leader in patient care.

Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, that combines powerful software and a robotic platform to offer minimally invasive therapies in liver cancer. [Read more…] about Stäubli Robotics and Quantum Surgical create ‘centre of excellence’ to develop oncology robotics

Broad cancer vaccine may be out of reach

March 1, 2017 by Mai Tao

The high level of genetic diversity between individual tumors suggests that if it were to be developed, a broad cancer vaccine would be unlikely to work for more than 0.3 per cent of the population, according to new research published in the open access journal Genome Medicine.

Next generation sequencing has revealed a wealth of information on the genetic diversity of tumors, which in turn has led to research into individualised treatments for cancer based on the molecular characteristics of a patient’s tumor.

Cancer vaccines are one type of prospective treatment that involves turning the patient’s immune system against the tumor.

Dr Ryan Hartmaier, lead author from Foundation Medicine, USA, said: “A broad or semi-universal vaccine capable of targeting many different tumors would be seen by some as the ‘holy grail’ of cancer therapy as it wouldn’t involve the time or cost of individualising treatment. [Read more…] about Broad cancer vaccine may be out of reach